Trials / Completed
CompletedNCT05507255
Effect of Aerobic Exercise on Diurnal Cortisol Pattern in Premenstrual Syndrome
Effect of Aerobic Exercise on Diurnal Cortisol Pattern in Premenstrual Syndrome: A Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- Cairo University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 23 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study will be to investigate the effect of aerobic exercise on diurnal cortisol pattern in premenstrual syndrome.
Detailed description
Premenstrual syndrome is manifested by recurrent emotional and depressive symptoms that may be associated with maladaptive coping with stress situations and the enhanced release of stress hormones, like cortisol hormone. Although previous studies revealed a flattened diurnal cortisol slope in women with PMS compared to healthy controls, there is no previous work on the effect of aerobic exercise on diurnal cortisol pattern in premenstrual syndrome. Therefore, this study will aim to investigate the effect of aerobic exercise participation on diurnal cortisol pattern in premenstrual syndrome.This trial will include two groups; group (A) will consist of 14 females who will receive relaxation training for 8 weeks, while group (B) will consist of 14 females who will receive the same relaxation training along with aerobic exercise for 8 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Relaxation training | Relaxation training in the form of deep breathing exercises |
| OTHER | An aerobic exercise program | An aerobic exercise program of a moderate intensity, based on the target heart rate (THR) that will be calculated in accordance with Karvonen's equation, using resting heart rate (HRrest), maximal heart rate (HRmax) and training fraction. THR = HRrest (bpm) + (HRmax (bpm) - HRrest (bpm)) × training fraction.The exercise session will have three phases, warming up, active phase and cooling down. |
Timeline
- Start date
- 2023-02-01
- Primary completion
- 2023-06-01
- Completion
- 2023-06-01
- First posted
- 2022-08-18
- Last updated
- 2023-06-27
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05507255. Inclusion in this directory is not an endorsement.